Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

170.84
Delayed Data
As of 3:59pm ET
 -3.56 / -2.04%
Today’s Change
130.09
Today|||52-Week Range
176.64
+5.24%
Year-to-Date
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
9:51am / Zacks.com - Paid Partner Content
Healthcare Dividend Growth Stocks: Part 1
Aug 12 / GuruFocus News - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Should Gilead Split in Two?
Aug 12 / TheStreet.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010
Aug 12 / MotleyFool.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen
Aug 12 / Zacks.com - Paid Partner Content
Gilead May Be Better Off Splitting Itself in Two, Analysts Say
Aug 18 / TheStreet.com - Paid Partner Content
Analysts: Gilead Should Divide Itself and Conquer
Aug 12 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
Aug 18 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat
Aug 11 / Zacks.com - Paid Partner Content
Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled
Aug 18 / Zacks.com - Paid Partner Content
4 Reasons Amgen, Inc. Shareholders Netted a 13% Gain in July
Aug 11 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
ETFs to Watch as Nasdaq Hits All-Time High
Aug 09 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
Stock Market News for August 09, 2016
Aug 09 / Zacks.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19
Aug 09 / Zacks.com - Paid Partner Content
Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010
Aug 13 / MotleyFool.com - Paid Partner Content
4 Nasdaq Stocks to Dazzle as the Index Hits All-Time High
Aug 08 / Zacks.com - Paid Partner Content
Martin Whitman's Third Avenue Management Purchases 8 Stocks
Aug 12 / GuruFocus News - Paid Partner Content